Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edelgard Lindhoff-Last

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
European Heart Journal|November 26, 2008
Incidence, clinical characteristics, and long-term prognosis of travel-associated pulmonary embolismRalf Lehmann, Christian Suess, Maria Leus, et al.
Thrombosis and Haemostasis|November 9, 2010
Impact of pharmacokinetic (CYP2C9) and pharmacodynamic (VKORC1, F7, GGCX, CALU, EPHX1) gene variants on the initiation and maintenance phases of phenprocoumon therapyBaete Luxembourg, Katharina Schneider, Katja Sittinger, et al.
Thrombosis and Haemostasis|May 2, 2008
Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolismMario Berger, Henriette Moscatelli, Bettina Kulle, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 14, 2009
Idiopathic (unexplained) pulmonary embolism is associated with an impaired prognosis compared to other entities of pulmonary embolismRalf Lehmann, Beate Luxembourg, Wolfgang Miesbach, et al.
Plos One|July 25, 2019
Evaluation of the sensitivity and specificity of a novel line immunoassay for the detection of criteria and non-criteria antiphospholipid antibodies in comparison to established ELISAsMarkus A Thaler, Andreas Bietenbeck, Udo Steigerwald, et al.
European Radiology|April 15, 2005
Percutaneous laser-assisted recanalization of long chronic iliac artery occlusions: primary and mid-term resultsJörn O Balzer, Verena Gastinger, Axel Thalhammer, et al.
British Journal of Haematology|November 14, 2013
Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registryLea Weingarz, Jan Schwonberg, Marc Schindewolf, et al.
Clinical Chemistry and Laboratory Medicine|May 27, 2016
Evaluation of antiphospholipid antibody assays using latent class analysis to address the lack of a reference standardMarkus A Thaler, Andreas Bietenbeck, Meng-Xin Yin, et al.
Thrombosis Research|July 12, 2011
Application, tolerance and safety of fondaparinux therapy in a German hospital: a prospective single-centre experienceMarc Schindewolf, Julia Scheuermann, Hartmut Kroll, et al.
Thrombosis and Haemostasis|November 8, 2013
Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiencyBeate Luxembourg, Anna Pavlova, Christof Geisen, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
European Heart Journal|November 26, 2008
Incidence, clinical characteristics, and long-term prognosis of travel-associated pulmonary embolismRalf Lehmann, Christian Suess, Maria Leus, et al.
Thrombosis and Haemostasis|November 9, 2010
Impact of pharmacokinetic (CYP2C9) and pharmacodynamic (VKORC1, F7, GGCX, CALU, EPHX1) gene variants on the initiation and maintenance phases of phenprocoumon therapyBaete Luxembourg, Katharina Schneider, Katja Sittinger, et al.
Thrombosis and Haemostasis|May 2, 2008
Association of ADAMDEC1 haplotype with high factor VIII levels in venous thromboembolismMario Berger, Henriette Moscatelli, Bettina Kulle, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 14, 2009
Idiopathic (unexplained) pulmonary embolism is associated with an impaired prognosis compared to other entities of pulmonary embolismRalf Lehmann, Beate Luxembourg, Wolfgang Miesbach, et al.
Plos One|July 25, 2019
Evaluation of the sensitivity and specificity of a novel line immunoassay for the detection of criteria and non-criteria antiphospholipid antibodies in comparison to established ELISAsMarkus A Thaler, Andreas Bietenbeck, Udo Steigerwald, et al.
European Radiology|April 15, 2005
Percutaneous laser-assisted recanalization of long chronic iliac artery occlusions: primary and mid-term resultsJörn O Balzer, Verena Gastinger, Axel Thalhammer, et al.
British Journal of Haematology|November 14, 2013
Prevalence of thrombophilia according to age at the first manifestation of venous thromboembolism: results from the MAISTHRO registryLea Weingarz, Jan Schwonberg, Marc Schindewolf, et al.
Clinical Chemistry and Laboratory Medicine|May 27, 2016
Evaluation of antiphospholipid antibody assays using latent class analysis to address the lack of a reference standardMarkus A Thaler, Andreas Bietenbeck, Meng-Xin Yin, et al.
Thrombosis Research|July 12, 2011
Application, tolerance and safety of fondaparinux therapy in a German hospital: a prospective single-centre experienceMarc Schindewolf, Julia Scheuermann, Hartmut Kroll, et al.
Thrombosis and Haemostasis|November 8, 2013
Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiencyBeate Luxembourg, Anna Pavlova, Christof Geisen, et al.
Pageof 12